362 related articles for article (PubMed ID: 24510652)
21. Exome sequencing explained: a practical guide to its clinical application.
Seaby EG; Pengelly RJ; Ennis S
Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982
[TBL] [Abstract][Full Text] [Related]
22. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.
Lin X; Tang W; Ahmad S; Lu J; Colby CC; Zhu J; Yu Q
Hear Res; 2012 Jun; 288(1-2):67-76. PubMed ID: 22269275
[TBL] [Abstract][Full Text] [Related]
23. Clinical exome sequencing-Mistakes and caveats.
Corominas J; Smeekens SP; Nelen MR; Yntema HG; Kamsteeg EJ; Pfundt R; Gilissen C
Hum Mutat; 2022 Aug; 43(8):1041-1055. PubMed ID: 35191116
[TBL] [Abstract][Full Text] [Related]
24. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting.
Münz M; Ruark E; Renwick A; Ramsay E; Clarke M; Mahamdallie S; Cloke V; Seal S; Strydom A; Lunter G; Rahman N
Genome Med; 2015 Jul; 7(1):76. PubMed ID: 26315209
[TBL] [Abstract][Full Text] [Related]
25. Gene and Variant Annotation for Mendelian Disorders in the Era of Advanced Sequencing Technologies.
Chakravorty S; Hegde M
Annu Rev Genomics Hum Genet; 2017 Aug; 18():229-256. PubMed ID: 28415856
[TBL] [Abstract][Full Text] [Related]
26. Genome-scale sequencing to identify genes involved in Mendelian disorders.
Markello TC; Adams DR
Curr Protoc Hum Genet; 2013 Oct; 79():6.13.1-6.13.19. PubMed ID: 24510651
[TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing: ready for the clinics?
Desai AN; Jere A
Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
[TBL] [Abstract][Full Text] [Related]
28. Detecting rare variants for psychiatric disorders using next generation sequencing: a methods primer.
Altmann A; Quast C; Weber P
Curr Psychiatry Rep; 2013 Jan; 15(1):333. PubMed ID: 23250814
[TBL] [Abstract][Full Text] [Related]
29. Genome analysis and knowledge-driven variant interpretation with TGex.
Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
[TBL] [Abstract][Full Text] [Related]
30. Detecting Causal Variants in Mendelian Disorders Using Whole-Genome Sequencing.
Hamzeh AR; Andrews TD; Field MA
Methods Mol Biol; 2021; 2243():1-25. PubMed ID: 33606250
[TBL] [Abstract][Full Text] [Related]
31. Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.
Hitomi Y; Tokunaga K
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(9):657-676. PubMed ID: 29129848
[TBL] [Abstract][Full Text] [Related]
32. Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies.
Seaby EG; Ennis S
Brief Funct Genomics; 2020 Jul; 19(4):243-258. PubMed ID: 32393978
[TBL] [Abstract][Full Text] [Related]
33. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
34. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
35. Next Generation Sequencing (NGS) Strategies for Genetic Testing of Cerebral Cavernous Malformation (CCM) Disease.
Benedetti V; Pellegrino E; Brusco A; Piva R; Retta SF
Methods Mol Biol; 2020; 2152():59-75. PubMed ID: 32524544
[TBL] [Abstract][Full Text] [Related]
36. Best practices for variant calling in clinical sequencing.
Koboldt DC
Genome Med; 2020 Oct; 12(1):91. PubMed ID: 33106175
[TBL] [Abstract][Full Text] [Related]
37. mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.
Li J; Jiang Y; Wang T; Chen H; Xie Q; Shao Q; Ran X; Xia K; Sun ZS; Wu J
J Med Genet; 2015 Apr; 52(4):275-81. PubMed ID: 25596308
[TBL] [Abstract][Full Text] [Related]
38. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
McInerney-Leo AM; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
[TBL] [Abstract][Full Text] [Related]
39. Whole-exome/genome sequencing and genomics.
Grody WW; Thompson BH; Hudgins L
Pediatrics; 2013 Dec; 132(Suppl 3):S211-5. PubMed ID: 24298129
[TBL] [Abstract][Full Text] [Related]
40. Analysis of pathogenic variants from the ClinVar database in healthy people using next-generation sequencing.
Rančelis T; Arasimavičius J; Ambrozaitytė L; Kavaliauskienė I; Domarkienė I; Karčiauskaitė D; Kučinskienė ZA; Kučinskas V
Genet Res (Camb); 2017 Aug; 99():e6. PubMed ID: 28851476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
